Myopia Clinical Trials
A listing of Myopia medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
Found 148 clinical trials
A Phase III, Randomized, Double-masked, Placebo-controlled, Parallel-group, Multicenter Study of the Safety and Efficacy of OT-101 (Atropine Sulfate 0.01%) in Treating the Progression of Myopia in Pediatric Subjects
treatment for myopia in pediatric subjects
- 110 views
- 16 Oct, 2022
- 7 locations
Virtual Eye Model System for Personalised Refractive Surgery Treatment
goal is to recruit 600 eyes from 300 patients, 100 patients in each of these groups: Myopia (from -10 D to -0.75 D) Emmetropia (from -0.5 D to + 0.5 D) Hyperopia (from 0.75 D to 5 D)
- 0 views
- 15 Oct, 2022
- 1 location
Low-dose Atropine for Myopia Control in Children, a Prospective, Double-blind, Placebo-controlled, Multicentric, Randomized Clinical Trial (AIM)
Myopia (nearsightedness) is the most common eye disorder. Only second to age, it is the main risk factor for major degenerative eye diseases such as glaucoma, macular degeneration or retinal
- 0 views
- 20 Oct, 2022
- 11 locations
Extended Depth of Focus Contact Lenses for Presbyopia
VTI has an FDA cleared soft contact lens product. Its optical design creates an enhanced depth of focus (EDOF), which provides clear distance, intermediate, and near vision. This study is to
- 0 views
- 22 Oct, 2022
- 1 location
INTACS® Prescription Inserts Used to Treat Patients With Keratoconus as a Humanitarian Use Device
The US food and Drug Administration (FDA) originally approved INTACS prescription inserts in April 1999 for the correction of low levels of nearsightedness (-1.00 to -3.00 diopters). Additional
- 37 views
- 23 Oct, 2022
- 1 location
STAAR Visian Toric ICL Post-Approval Study (TICL-PAS)
The objective of this study is to evaluate the long term (i.e. 24 months) clinical performance of the Visian® Toric Implantable Collamer® Lens (ICL).
- 250 views
- 04 Oct, 2022
- 8 locations
Theranostic Guided Riboflavin/UV-A Corneal Cross-linking (ARGO)
This is a clinical study consisting of a study arm to assess the performance of the theranostic software module (Research Use Only) of a CE marked (CE1936) UV-A medical device, C4V CHROMO4VIS™, in order to validate its use for theranostic-guided corneal cross-linking treatment of keratoconus and corneal ectasia. The study …
- 0 views
- 04 Oct, 2022
- 2 locations
Progressive Myopia Treatment Evaluation for NaturalVue Multifocal Contact Lens Trial (PROTECT)
This is a multi-center, randomized, double-masked clinical trial. All study devices are market approved/cleared in the localities where the study is conducted. Subjects will be randomly assigned to wear NaturalVue Sphere single vision contact lenses (SVCL) or NaturalVue Multifocal (NVMF) soft contact lenses for a total of three years.
- 0 views
- 28 Oct, 2022
- 7 locations
MiSight 1 Day Safety Post-Approval Study
The purpose of this post-approval study is to confirm the safety of daily disposable soft contact lens wear among the intended patient population for the MiSight 1 Day lens in the US.
- 0 views
- 25 Oct, 2022
- 1 location
New Technology and Child Health
Background We are involved in testing new behavioral science methods and measures for future research projects. In the course of these evaluations, we will also test research questions related to parents psychological experiences and how these relate to the responses they have when they encounter different types of communication about …
- 3 views
- 18 Oct, 2022
- 1 location